NOV 20, 2018 01:00 AM CET

Advanced optical hematology technology for elevated analytical performance

SPONSORED BY: Abbott Diagnostics
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Manager, Medical and Scientific Affairs, Abbott Hematology
    Biography
      Dr. Zainab Mukhtar is working as a Global Manager, Medical and Scientific Affairs for Abbott Hematology based in Abbott Delkenheim office in Germany. She is a Medical Physician, specialized in hematology blood transfusion and transplantation medicine from Bristol University, UK. Her thesis work was in the laboratory of histocompatibility and immunogenetics at NHSBT Filton, UK under the supervision of Dr. John Harvey related to STR markers in transplants of acute pediatric leukemia's. She also additionally acquired Assessor's Certification from Paul Ehrlich Institute, Germany. Her more than 16 years of post-graduate experience includes hematology and blood bank laboratory management, clinical management of hematology and transfusion dependent patients of various hematological disorders and Consulting, for Hematology and Blood Transfusion Projects in various countries. She has been actively presenting her research work in various hematological and blood transfusion Societies in the world and been an active member of ISBT and was the recipient of various scholarship awards like Harold Gunson Fellowship-ISBT, World Hemophilia Society Fellowship and CSSS British Scholarship. She has also studied Health Care Business Management and has experience of Commercial Hematology in Abbott Diagnostics in the region Middle East, Srilanka and Pakistan during which she also supported hematology laboratories of the region. Her main areas of research interest are, recent advancements in hematological diagnostics, quality management in hematology and blood transfusion, hemoglobinopathies, transfusion dependent anemias, hemovigilance, transfusion transmitted infectious diseases, and Pediatric Leukemia. Zainab is also a dedicated volunteer and member of various Women Professional Societies and committed to advancements of women in Science and Leadership.

    Abstract:
    DATE:  November 20, 2018
     
    Europe: 09:00 GMT/WET 10:00 CET / 12:00 MST
    Middle East:  12:00 TRT / 13:00 GST
    Asia/Pacific:  17:00 SGT / 14:30 IST
    Americas:  06:00 ART / 01:00 PDT / 04:00 EDT
     
    Today, hematology analyzers can collect vast amounts of data about cell characteristics, that subsequently improve disease detection. Advanced systems can perform a complete blood count (CBC) and classify multiple cell types, including more than the normal five subclasses of mature white blood cells. They also produce improved flagging of abnormal results to aid further microscopic review. Multi Angle Polarized Scatter Separation (MAPSS™), an optical technology is utilized in Abbott’s hematology analyzers. Abbott’s latest hematology system employs an advanced version of MAPSS technology, as well as a learning algorithm to provide enhanced differentiation of blood cells. In addition, analysis of red blood cells and platelets are performed using entirely optical technology, allowing for the introduction of additional parameters.
     
    In this HIT SERIES, Dr. Mukhtar will review the general principles and capabilities of Abbott’s Advanced MAPSS technology and review a series of cases produced by the hematology system that employs Advanced MAPSS.
     
    Learning Objectives:
     
    • Describe Advanced MAPSS technology: measurement principles, detectors, reportable parameters, morphological flags, workflow efficiency and demonstration of relevant cases.
    • Discuss RBC/PLT separation using Advanced MAPSS in comparison to impedance and that enables additional parameters. Efficiently demonstrate the relevant cases of microcytic hypochromic anemia and schistocytes with intravascular hemolysis.
    • Review platelet analysis, flags and reticulated platelets in comparison to CD61 and impedance methods with a case demonstration using Advanced MAPSS technology.
     
    Don't miss a future webinar. Sign up today to receive updates.
     
     
     

    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUN 26, 2019 09:00 AM PDT
    C.E. CREDITS
    JUN 26, 2019 09:00 AM PDT
    DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources